Adverum Biotechnologies saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Adverum Biotechnologies’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Adverum Biotechnologies has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 20% of filings. The World Intellectual Property Organization(WIPO), European Patent Office(EPO), Japan(JP), and Canada(CA) patent Office are among the top ten patent offices where Adverum Biotechnologies is filings its patents. Among the top granted patent authorities, Adverum Biotechnologies has 50% of its grants in Canada(CA) and 50% in Spain(ES).
University of Pennsylvania could be the strongest competitor for Adverum Biotechnologies
Patents related to genomics and rare diseases lead Adverum Biotechnologies's portfolio
Adverum Biotechnologies has the highest number of patents in genomics followed by, rare diseases. For genomics, nearly 50% of patents were filed and no patents were granted in Q2 2024.
Ophthalmic devices related patents lead Adverum Biotechnologies portfolio followed by viral conjunctivitis, and cryopyrin-associated periodic syndromes
Adverum Biotechnologies has highest number of patents in ophthalmic devices followed by viral conjunctivitis, cryopyrin-associated periodic syndromes, glaucoma, and neovascular glaucoma. For ophthalmic devices, nearly 17% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Adverum Biotechnologies's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
